Linda Yaccarino joins eMed as CEO after departing Musk’s X

Published 05/08/2025, 16:02
Linda Yaccarino joins eMed as CEO after departing Musk’s X

Investing.com -- Linda Yaccarino has been appointed Chief Executive Officer of eMed Population Health, a digital health platform specializing in GLP-1/GIP population health management, after recently leaving her position as CEO of Elon Musk’s X social media platform.

eMed, a telehealth company that provides access to weight-loss drugs, announced the appointment as a strategic move to advance its mission of making chronic care more accessible through digital-first experiences.

The company’s board of directors views Yaccarino’s arrival as an opportunity to bring in a leader who successfully managed one of the world’s most complex digital platforms. Her experience is expected to help accelerate eMed’s goal of revolutionizing chronic care delivery.

Before joining X, Yaccarino served as chairman of global advertising and partnerships at NBCUniversal, where she oversaw advertising, partnerships, and strategic initiatives. During her tenure, she helped create a global cross-sell platform that became an industry standard.

"The healthcare industry has been disrupted by technology, but not yet completely transformed by it," Yaccarino said. "There is an opportunity to combine technology, lifestyle, and data in a new powerful way through the digital channels that impact consumers directly in ways that have never been done before."

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.